4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chemotherapy for metastatic colorectal cancer
    Book Section

    Power, D. G.; Kemeny, N. E.
    In Poston, G. J.; D'Angelica, M.; Adam, R. (Eds.) Surgical Management of Hepatobiliary and Pancreatic Disorders. 2nd ed (2010)

    Fulltext@MSK | Save
  • Treatment of liver metastases
    Book Section

    Kemeny, N. E.; D'Angelica, M.
    In Hong, W. K.; Bast, R. C. Jr; Hait, W. N.; Kufe, D. W.; Pollock, R. E.; Weichselbaum, R. R.; Holland, J. F.; Frei, E. 3rd (Eds.) Holland-Frei Cancer Medicine. 8th ed (2010)

    Fulltext@MSK | Save
  • Dynamic contrast enhanced MRI (DCE-MRI) to measure antiangiogenic therapy and predict treatment response in primary liver cancer (PLC)
    Meeting Abstract

    Yopp, A. C.; Schwartz, L. H.; Kemeny, N. E.; Gultekin, D.; Gonen, M.; Bamboat, Z.; Shia, J.; D'Angelica, M. I.; DeMatteo, R. P.; Jarnagin, W. R.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Vitamin D levels and survival in colorectal cancer (CRC)
    Meeting Abstract

    Wesa, K. M.; Jacobs, G.; Woo, D.; Cronin, A.; Segal, N. H.; Coleton, M.; Saltz, L.; Cassileth, B. R.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Association between smoking history and disease-free and overall survival in resected gastric cancer
    Meeting Abstract

    Smyth, E. C.; Strong, V. E.; Capanu, M.; Janjigian, Y. Y.; Coit, D. G.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Perioperative chemotherapy plus bevacizumab with early salvage therapy based on PET response in patients with locally advanced resectable gastric/GEJ cancer
    Meeting Abstract

    Smyth, E. C.; Schoder, H.; Coit, D. G.; Strong, V. E.; Brennan, M. F.; Janjigian, Y. Y.; Capanu, M.; Tang, L. H.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Random assignment multicenter phase II study of modified docetaxel, cisplatin, fluorouracil (mDCF) versus DCF with growth factor support (GCSF) in metastatic gastroesophageal adenocarcinoma (GE)
    Meeting Abstract

    Shah, M. A.; Shibata, S.; Stoller, R. G.; Kemeny, M.; Ritch, P. S.; Krishnamurthi, S. S.; Su, Y. B.; Janjigian, Y. Y.; Capanu, M.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060)
    Meeting Abstract

    Shah, M. A.; Smyth, E. C.; Shibata, S.; Yong, W.; Tang, L. H.; Janjigian, Y. Y.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Azzoli, C. G.; Pietanza, M.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Pao, W.; Ginsberg, M. S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The role of octreotide imaging in detecting neuroendocrine tumors (NETs) in 2010: Do we still need it?
    Meeting Abstract

    Saltz, L.; Gollub, M.; Reidy, D. L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save